- Home
- DVAX vs SVV Comparison
DVAX vs SVV Comparison
Compare DVAX & SVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- SVV
- Stock Information
- Founded
- DVAX 1996
- SVV 1954
- Country
- DVAX United States
- SVV United States
- Employees
- DVAX N/A
- SVV N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- SVV Other Specialty Stores
- Sector
- DVAX Health Care
- SVV Consumer Discretionary
- Exchange
- DVAX Nasdaq
- SVV Nasdaq
- Market Cap
- DVAX 1.5B
- SVV 1.7B
- IPO Year
- DVAX 2004
- SVV 2023
- Fundamental
- Price
- DVAX $12.21
- SVV $9.17
- Analyst Decision
- DVAX Buy
- SVV Buy
- Analyst Count
- DVAX 2
- SVV 5
- Target Price
- DVAX $22.00
- SVV $12.00
- AVG Volume (30 Days)
- DVAX 3.3M
- SVV 856.5K
- Earning Date
- DVAX 11-07-2024
- SVV 11-07-2024
- Dividend Yield
- DVAX N/A
- SVV N/A
- EPS Growth
- DVAX N/A
- SVV 89.47
- EPS
- DVAX 0.15
- SVV 0.44
- Revenue
- DVAX $260,810,000.00
- SVV $1,518,397,000.00
- Revenue This Year
- DVAX $23.13
- SVV $3.58
- Revenue Next Year
- DVAX $19.60
- SVV $7.79
- P/E Ratio
- DVAX $80.80
- SVV $20.64
- Revenue Growth
- DVAX N/A
- SVV 2.30
- 52 Week Low
- DVAX $9.74
- SVV $7.78
- 52 Week High
- DVAX $15.01
- SVV $21.33
- Technical
- Relative Strength Index (RSI)
- DVAX 52.22
- SVV 38.35
- Support Level
- DVAX $11.61
- SVV $9.45
- Resistance Level
- DVAX $13.74
- SVV $10.05
- Average True Range (ATR)
- DVAX 0.52
- SVV 0.52
- MACD
- DVAX 0.09
- SVV -0.12
- Stochastic Oscillator
- DVAX 32.80
- SVV 0.51
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books and other goods from its non-profit partners ("NPPs"), either directly from them or via on-site donations ("OSDs") at Community Donation Centers at its stores. The company then process, selects, price, merchandise and sell these items in its stores.